Curious about this stock
**February 2026:** US government awarded a **US$41m sole-source development contract** through the Defense Health Agency Contracting Activity, 36-month period of performance. It funds Phase 3 *and* the regulatory work required for an Emergency Use Authorization for Department of Defense use.
**September 2026:** a declaration was published under **Section 564 of the FD&C Act**, the statutory precondition before the FDA may even consider an EUA. It followed military determinations regarding combat casualty care.
**7 September 2026:** the company stated it expects to complete its EUA submission in **Q4 2026**.
For a smallish stock in Singapore, this seems to be showing positive signs for this company to work with the US government which could be a big deal. The EUA and US government contact looks to be a massive driver for it to move to the next stage.
What are all your thoughts?